We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.13%
2 Consumer Discretionary 10.52%
3 Financials 9.9%
4 Healthcare 8.91%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMCB icon
5651
PharmaCyte Biotech
PMCB
$5.91M
$2K ﹤0.01%
650
-6,420
-91% -$17.7K
PMM
5652
Franklin Managed Municipal Income Trust
PMM
$272M
$2K ﹤0.01%
+276
New +$2.35K
REFR icon
5653
Research Frontiers
REFR
$17.1M
$2K ﹤0.01%
+1,029
New +$2.2K
RGLS
5654
DELISTED
Regulus Therapeutics
RGLS
$2K ﹤0.01%
+684
New +$3.04K
RNGR icon
5655
Ranger Energy Services
RNGR
$401M
$2K ﹤0.01%
183
-506
-73% -$5.14K
SAN icon
5656
Banco Santander
SAN
$211B
$2K ﹤0.01%
494
-41,763
-99% -$147K
SBS icon
5657
Sabesp
SBS
$17.8B
$2K ﹤0.01%
1,083
+366
+51% +$475
SCLX icon
5658
Scilex Holding
SCLX
$47.5M
$2K ﹤0.01%
+5
New +$1.76K
OLOX
5659
Olenox Industries
OLOX
$4.24M
0
SGLY icon
5660
Singularity Future Technology
SGLY
$5.51M
$2K ﹤0.01%
2
-40
-95% -$18.8K
SLNO
5661
DELISTED
Soleno Therapeutics
SLNO
$2K ﹤0.01%
+319
New +$3.35K
DCOY
5662
Decoy Therapeutics
DCOY
$1.99M
0
SNES icon
5663
SenesTech
SNES
$6.83M
$2K ﹤0.01%
+1
New +$3.2K
SNOA icon
5664
Sonoma Pharmaceuticals
SNOA
$6.41M
$2K ﹤0.01%
26
-45
-63% -$4.81K
SQFT icon
5665
Presidio Property Trust
SQFT
$1.83M
$2K ﹤0.01%
45
-154
-77% -$5.89K
STRS
5666
DELISTED
STRATUS PPTYS INC
STRS
$2K ﹤0.01%
+51
New +$1.75K
SUPV
5667
Grupo Supervielle
SUPV
$731M
$2K ﹤0.01%
967
+844
+686% +$1.81K
TMQ
5668
Trilogy Metals
TMQ
$665M
$2K ﹤0.01%
1,500
+100
+7% +$184
STLN
5669
Starling Oncology, Inc. Common Stock
STLN
$630M
$2K ﹤0.01%
200
-252
-56% -$2.24K
TRT
5670
Trio-Tech International
TRT
$113M
$2K ﹤0.01%
254
-1,312
-84% -$4.73K
UDOW icon
5671
ProShares UltraPro Dow 30
UDOW
$930M
$2K ﹤0.01%
40
-6,412
-99% -$255K
UG icon
5672
United-Guardian
UG
$33.1M
$2K ﹤0.01%
140
-730
-84% -$11K
UNG icon
5673
United States Natural Gas Fund
UNG
$501M
$2K ﹤0.01%
30
-1,708
-98% -$111K
USCB icon
5674
USCB Financial Holdings
USCB
$416M
$2K ﹤0.01%
153
-3,370
-96% -$46.6K
UUP icon
5675
Invesco DB US Dollar Index Bullish Fund
UUP
$414M
$2K ﹤0.01%
64
-101
-61% -$2.58K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.